Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqGS:FLNC
NasdaqGS:FLNCElectrical

Fluence Energy Weighs New Director And ESOP Shelf In Growth Plans

Fluence Energy (NasdaqGS:FLNC) appointed Fahad Al-Darwish to its board of directors at its recent Annual Meeting. The company also filed a significant shelf registration, creating flexibility for potential future capital raising. Fluence Energy focuses on grid scale energy storage solutions, a segment that sits at the center of power system reliability and the integration of renewables. As battery technologies, grid modernization efforts, and policy support continue to shape the sector,...
ASX:WAF
ASX:WAFMetals and Mining

Surging 2025 Sales And Earnings Might Change The Case For Investing In West African Resources (ASX:WAF)

West African Resources Limited has reported its full-year 2025 results, with sales rising to A$1,543 million and net income reaching A$473.9 million, both higher than the prior year. The improvement in basic earnings per share from A$0.207 to A$0.416 highlights how increased production and cost control have flowed through to shareholders. We’ll now examine how this sharp uplift in annual sales and earnings reshapes West African Resources’ investment narrative and future prospects. Outshine...
NYSE:ABR
NYSE:ABRMortgage REITs

Does Insider Buying Amid Rising Non-Performing Loans Change The Bull Case For Arbor Realty Trust (ABR)?

In recent months, Arbor Realty Trust has become a flashpoint in the mortgage REIT space as CEO Ivan Kaufman and other insiders bought shares while the company executed stock repurchases, even as short-sellers cited concerns about US$569.10 million of non-performing loans and the resilience of its dividend. This standoff between insider confidence and bearish short interest turns the eventual outcome of Arbor’s large non-performing loan portfolio into a critical test of its risk management...
TSX:NGD
TSX:NGDMetals and Mining

Is It Time To Reassess New Gold (TSX:NGD) After The Recent Share Price Pullback

Investors may be wondering whether New Gold's current share price still offers value after a strong run, or if most of the opportunity is already reflected in the market. The stock recently pulled back, with a 14.6% decline over the last week and a 15.3% decline over the past month, even though the 1 year return sits at 161.4% and the year to date return is 5.9%. This combination of sharp short term weakness and very strong longer term gains has put New Gold back on the radar for investors...
TSX:SEA
TSX:SEAMetals and Mining

Assessing Seabridge Gold’s Valuation After A Sharp Pullback In Recent Weeks

Recent performance snapshot for Seabridge Gold With no single headline event driving the move, Seabridge Gold (TSX:SEA) has drawn attention after a 21.9% decline over the past week and a 30.7% slide over the past month. Despite these recent pullbacks, the stock shows a 1-year total return of 97.1% and a 3-year total return close to 7x, which may help put the current price action into context for investors. See our latest analysis for Seabridge Gold. Recent trading has shifted sharply, with a...
TSX:CDR
TSX:CDROil and Gas

Condor Energies Loss Reduction Trend Tests Bullish Valuation Narrative After FY 2025 Results

Condor Energies (TSX:CDR) has reported its FY 2025 numbers with Q4 total revenue of C$17.6 million and a basic EPS loss of C$0.03, alongside trailing twelve month revenue of C$69.5 million and a basic EPS loss of C$0.06. Over recent quarters, the company has seen quarterly revenue range from C$16.2 million to C$19.2 million, while basic EPS has stayed in loss making territory between C$0.00 and C$0.06, keeping the focus firmly on how efficiently each dollar of sales is being converted into...
TSX:NEO
TSX:NEOChemicals

Neo Performance Materials (TSX:NEO) Is Down 19.6% After Narrower Annual Loss And Steady Dividend – Has The Bull Case Changed?

Neo Performance Materials recently reported fourth‑quarter 2025 results showing sales of US$120.27 million and a net loss of US$15.64 million, while full‑year sales edged up to US$478.79 million with a reduced annual net loss of US$9.98 million. Alongside this, the company kept its quarterly dividend at C$0.10 per share and highlighted progress in higher‑value areas such as permanent magnets and portfolio simplification, pointing to an emphasis on operational efficiency and downstream growth...
NasdaqGS:NBIS
NasdaqGS:NBISSoftware

Meta AI Megadeal And NVIDIA Tie-Up Might Change The Case For Investing In Nebius Group (NBIS)

Nebius Group has recently completed US$4.00 billion of convertible note offerings and secured an AI infrastructure agreement with Meta Platforms worth up to US$27.00 billion, alongside a US$2.00 billion investment and technology partnership with NVIDIA. These deals collectively deepen Nebius’s role as an AI-first cloud provider at the center of hyperscalers’ GPU capacity needs, while locking in long-duration demand visibility across its expanding data center footprint. We’ll now examine how...
NYSE:VST
NYSE:VSTRenewable Energy

Is It Time To Reassess Vistra (VST) After Its Recent Share Price Pullback

If you are wondering whether Vistra's current share price lines up with its underlying worth, you are not alone. This article focuses on exactly that question. After a very strong multi year run, the stock has recently pulled back, with a 7 day return of an 8.1% decline, a 30 day return of a 14.8% decline, and a year to date return of an 11.6% decline from a last close of US$146.02. That recent share price softness comes after a very large 3 year return and an even stronger 5 year return...
XTRA:TPE
XTRA:TPESemiconductor

PVA TePla (XTRA:TPE) Margin Compression To 6.3% Puts Growth Narratives Under Scrutiny

PVA TePla (XTRA:TPE) has wrapped up FY 2025 with fourth quarter revenue of €68.9 million and basic EPS of €0.07, closing out a year where trailing twelve month revenue stood at €244.3 million and EPS at €0.37. Over recent quarters, revenue has moved from €71.8 million in Q4 2024 to €55.8 million in Q3 2025 and then €68.9 million in Q4 2025. Quarterly EPS shifted from €0.42 in Q4 2024 to a small loss in Q3 2025 before recovering to €0.07 in the latest quarter, leaving investors focused on how...
NYSE:CAG
NYSE:CAGFood

Conagra Brands (CAG) Is Down 7.6% After Mixed Q2 2026 Earnings and Bearish Options Activity

Recently, Conagra Brands reported mixed Q2 2026 earnings, and a cautious outlook from a sector peer added to investor uncertainty around the food group. This combination has sparked heightened attention on Conagra’s fundamentals, with increased bearish options activity signaling concern ahead of the next earnings update. Now, we’ll examine how this mixed earnings picture and rising caution among options traders might reshape Conagra Brands’ investment narrative. Invest in the nuclear...
NasdaqGS:LYFT
NasdaqGS:LYFTTransportation

How Investors May Respond To Lyft (LYFT) Tapping NVIDIA AI For Rideshare And Autonomous Fleet Overhaul

In March 2026, Lyft announced it would integrate NVIDIA’s AI Enterprise tools and DRIVE Hyperion platform to upgrade its global rideshare machine learning, mapping, and future Level 4 autonomous fleet architecture across its operations, including the recently acquired Freenow network in Europe. This collaboration ties NVIDIA’s broad AI ecosystem directly into Lyft’s large-scale mobility data and multi-modal footprint, potentially reshaping how the company runs core marketplace, mapping, and...
NasdaqGS:EXTR
NasdaqGS:EXTRCommunications

Did Extreme’s Healthcare Push and EPEAT-Certified Gear Just Shift Extreme Networks’ (EXTR) Investment Narrative?

Cellhub, a healthcare technology aggregator and Primary Agent for T-Mobile, recently announced a partnership with Extreme Networks to supply secure, high-performance wired, wireless, and cellular networking for its Hospitals Without Walls initiative, targeting highly regulated and high-density care settings. Separately, Extreme Networks becoming the first networking vendor with EPEAT-registered switches and access points adds an environmental compliance angle that may appeal to governments...
NasdaqGS:ADBE
NasdaqGS:ADBESoftware

CEO Shift And NVIDIA-Backed AI Push Could Be A Game Changer For Adobe (ADBE)

In March 2026, Adobe reported first-quarter revenue of US$6.40 billion and net income of US$1.89 billion, announced CEO Shantanu Narayen’s planned transition, expanded its Major League Baseball partnership, and deepened its AI collaboration with NVIDIA across Firefly, Acrobat, and 3D digital twin workflows. At the same time, Adobe is facing questions about its annual recurring revenue momentum, renewed AI competition from companies such as Google, and regulatory scrutiny over early...
NYSE:RDDT
NYSE:RDDTInteractive Media and Services

Can Pacvue’s Reddit Ads Integration Subtly Redefine Reddit’s (RDDT) Enterprise Advertising Scale Ambitions?

In mid-March 2026, Pacvue announced a partnership with Reddit to integrate Reddit Ads into Pacvue’s Commerce Operating System, enabling enterprise brands and agencies to plan, activate, and optimize campaigns across Reddit’s 121 million daily visitors and 100,000-plus active communities within a unified workflow. This move connects Reddit’s community-driven, high-intent audiences with Pacvue’s AI-powered tools for cross-channel governance, automation, and creative intelligence, potentially...
SEHK:1877
SEHK:1877Biotechs

Is It Time To Reassess Shanghai Junshi Biosciences (SEHK:1877) After Its Recent Share Price Strength

If you are wondering whether Shanghai Junshi Biosciences at HK$21.90 still offers value after a strong run, this breakdown will help you frame the opportunity and the risks in a structured way. The stock has returned 9.2% over the past week and 4.5% over the last 30 days, with a 51.0% return over the past year but a 1.7% decline year to date and deeper losses over 3 and 5 years. These mixed figures may leave you questioning whether the recent strength signals a shift in sentiment or just...
NasdaqGS:FSLY
NasdaqGS:FSLYIT

Fastly (FSLY) Valuation Check After New Data Partnership And Rising AI Security Interest

Fastly (FSLY) is back in focus after renewing its collaboration with Dublin based data platform Bronto IO and launching new tools aimed at real time, cost conscious insights on complex log data. See our latest analysis for Fastly. The renewed Bronto IO partnership and focus on AI related security use cases arrive after a powerful run, with a 30 day share price return of 33.83% and a 1 year total shareholder return of 254.43%. This suggests strong momentum even after recent short term...
NasdaqGS:COLM
NasdaqGS:COLMLuxury

How Weak Growth and Flat Cash Flows At Columbia Sportswear (COLM) Have Changed Its Investment Story

Recent commentary on Columbia Sportswear highlights that, despite earlier stock outperformance, the company continues to face weak constant-currency revenue growth, flat free cash flow projections, and declining return on invested capital, pointing to soft demand and limited profitable expansion opportunities as of March 22, 2026. This combination of muted growth, constrained cash generation, and lower returns suggests that Columbia Sportswear may have fewer levers to improve its underlying...
SEHK:1918
SEHK:1918Real Estate

Sunac China Holdings (SEHK:1918) Valuation After Narrowed 2025 Loss Guidance And Ongoing Debt Restructuring

Sunac China Holdings (SEHK:1918) has issued unaudited earnings guidance for 2025, indicating an expected loss of RMB 12.0 billion to RMB 13.0 billion, compared with a loss of about RMB 25.70 billion in 2024. See our latest analysis for Sunac China Holdings. The updated 2025 guidance comes after a difficult stretch for shareholders, with a 1-year total shareholder return decline of 29.09% and a 5-year total shareholder return decline of 96.08%. The latest HK$1.17 share price reflects weaker...
NYSE:HPQ
NYSE:HPQTech

Assessing HP (HPQ) Valuation After Prolonged Share Price Weakness

HP (HPQ) is on investors’ radar after recent trading left the share price around $18.27, with returns negative over the past month and past 3 months, and the 1 year total return also negative. See our latest analysis for HP. The recent 1 day share price return of a 1.14% decline and 7 day share price return of a 3.49% decline sit within a weaker pattern, with the 90 day share price return down 21.45% and the 1 year total shareholder return down 33.08%, suggesting momentum has been fading...
NasdaqGS:CDNS
NasdaqGS:CDNSSoftware

Is It Time To Reassess Cadence Design Systems (CDNS) After Strong Multi‑Year Share Gains?

If you are looking at Cadence Design Systems and wondering whether the current share price lines up with the underlying value, the numbers offer a few clear starting points to work from. The stock last closed at US$283.90, with returns of a 1.1% decline over 7 days, a 6.9% decline over 30 days, an 8.5% decline year to date, and gains of 8.2% over 1 year, 38.8% over 3 years, and 114.1% over 5 years. These mixed shorter term and longer term returns put more focus on how the current price...
NYSE:NBHC
NYSE:NBHCBanks

Is National Bank Holdings (NBHC) Pricing Look Interesting After Recent Share Price Weakness?

If you are wondering whether National Bank Holdings at around US$37.48 is a bargain or just fairly priced, the next sections will help you put that question under the microscope. The share price has slipped around 3.5% over the last week and 9.8% over the past month, while the 1 year return sits close to flat at 0.4% and the 3 year return is 22.9%. Recent coverage has focused on how regional banks are being priced by the market and where investors see potential risks and opportunities within...
SEHK:9886
SEHK:9886Consumer Retailing

Dingdang Health Technology Group (SEHK:9886) Loss Narrows To C¥51.7m Challenging Bearish Narratives

Dingdang Health Technology Group (SEHK:9886) has posted its FY 2025 first half results with revenue of C¥2.3b, a basic EPS loss of C¥0.04 per share and net income loss of C¥51.7m, keeping the focus firmly on the path toward breakeven. Over the recent reporting periods, revenue has moved from C¥2.27b in 1H 2024 to C¥2.40b in 2H 2024 and C¥2.33b in 1H 2025, while basic EPS losses have shifted from C¥0.06 in 1H 2024 to C¥0.22 in 2H 2024 and C¥0.04 in 1H 2025. This sets up an earnings season...
NasdaqGS:RARE
NasdaqGS:RAREBiotechs

A Look At Ultragenyx Pharmaceutical (RARE) Valuation After Recent Share Price Weakness

Ultragenyx Pharmaceutical (RARE) has drawn fresh investor attention after recent share price moves, with the stock closing at US$19.87 and sitting well below its 1 year and past 3 months performance levels. See our latest analysis for Ultragenyx Pharmaceutical. The recent weakness follows a much steeper 40.7% 90 day share price decline and a 49.3% 1 year total shareholder return loss, signaling fading momentum as investors reassess both growth prospects and risk around the pipeline and...